Nocturnal Panic Attacks: Symptoms, Causes, Impacts, and Treatment

Nocturnal panic attacks are sudden surges of fear and autonomic distress that jolt a person awake from non-rapid eye movement (NREM) sleep with no dream, no external trigger, and no visible threat to explain them.

Unlike nightmares, they originate from NREM sleep, not from dreaming. Unlike sleep terrors, the individual wakes fully aware and recalls the entire episode.

They are a recognized feature of panic disorder that disrupts sleep architecture, drives progressive sleep avoidance, and compounds co-occurring anxiety and depression without targeted treatment.

Understanding what drives nocturnal panic attacks, how long they last, and what evidence-based treatment achieves is what separates chronic suffering from sustained recovery.

Key Takeaways

• A meta-analysis published in PLOS Mental Health (December 2025) confirmed that over 50% of patients with panic disorder report at least one nocturnal panic episode, establishing nighttime panic as a core clinical feature rather than a rare complication of the disorder.
• According to polysomnographic research (Nakamura et al., 2013), nocturnal panic attacks arise during NREM sleep, specifically during the Stage 2 to Stage 3 transition, predominantly in the first tertile of the night within 1 to 3 hours of sleep onset, not during dreaming.
• The false suffocation alarm theory (Klein, 1993) and carbon dioxide (CO2) hypersensitivity provide the leading neurobiological explanation for why locus coeruleus norepinephrine discharge produces panic spontaneously during NREM sleep.
• According to the National Institute of Mental Health (NIMH), panic disorder responds strongly to cognitive behavioral therapy (CBT) and SSRIs, with most individuals achieving significant reduction or full remission of nocturnal panic with appropriate evidence-based clinical care.
• PTSD, generalized anxiety disorder (GAD), major depressive disorder (MDD), and obstructive sleep apnea (OSA) are the conditions most strongly associated with nocturnal panic attacks, each through a distinct neurobiological pathway requiring targeted treatment.

What Are Nocturnal Panic Attacks?

Nocturnal panic attacks are abrupt autonomic nervous system activation events that arise from NREM sleep, producing tachycardia, dyspnea, and overwhelming fear before the individual completes the transition to full wakefulness.

Nocturnal vs. Daytime Panic Attacks

Nocturnal panic attacks meet the same DSM-5 diagnostic criteria as daytime panic attacks but differ in sleep stage of origin, timing within the sleep cycle, and their disproportionate impact on sleep architecture, sleep safety, and behavioral avoidance.

Key distinctions between nocturnal and daytime panic attacks:

• Sleep stage of origin: nocturnal panic attacks originate exclusively during NREM sleep (primarily the Stage 2 to Stage 3 transition), while daytime attacks arise during wakefulness; this means nocturnal attacks cannot arise from dreams and are not caused by nightmares
• Timing within the sleep cycle: polysomnography confirms most nocturnal panic attacks occur in the first tertile of the night, approximately 1 to 3 hours after sleep onset, during the deepest NREM slow-wave period rather than during the REM-heavy second half when dreaming predominates
• Spontaneous character: both attack types are unexpected and cue-independent, but nocturnal attacks produce more intense fear of physical illness or death because the individual cannot attribute severe cardiovascular symptoms to any visible stressor or social context
• Sleep architecture impact: a polysomnographic study of 20 nocturnal panic patients found increased NREM Stage 1 (shallow sleep), decreased NREM Stage 3 (slow-wave sleep), reduced sleep efficiency, and increased arousal frequency compared to healthy controls

Differentiating Nocturnal Panic Attacks from Similar Events

Nocturnal panic attacks are frequently misdiagnosed as nightmares, sleep terrors, or nocturnal seizures, delaying accurate diagnosis and targeted treatment by months to years in many clinical presentations.

Event	Sleep Stage	Full Wakefulness	Memory of Episode	Primary Feature
Nocturnal panic attack	NREM Stage 2-3 transition	Yes	Yes, vivid	Tachycardia, dyspnea, overwhelming fear
Nightmare	REM sleep	Yes	Yes, dream content recalled	Distressing dream narrative
Sleep terror	NREM Stage 3	No (partial)	No recall in morning	Screaming, no distress on awakening
Nocturnal seizure	Any stage	Variable	Variable	Motor activity predominates

The absence of dream content upon awakening is the most reliable differentiator between a nocturnal panic attack and a nightmare. Complete wakefulness and full recall of the episode differentiates nocturnal panic from sleep terrors.

What Causes Nocturnal Panic Attacks?

Nocturnal panic attacks are caused by a spontaneous locus coeruleus norepinephrine discharge during NREM sleep that activates the sympathetic nervous system as if a life-threatening emergency is occurring, without any external trigger to justify the response.

The Locus Coeruleus Norepinephrine Surge

The neurobiological sequence producing a nocturnal panic attack follows a specific cascade driven by locus coeruleus dysregulation during the NREM Stage 2 to Stage 3 transition.

Neurobiological sequence of nocturnal panic onset:

• Normal NREM suppression: locus coeruleus firing rate decreases during NREM sleep, maintaining the low-arousal state required for restorative slow-wave activity and HPA axis cortisol recovery
• Spontaneous dysregulation: in individuals with panic disorder, the locus coeruleus fires aberrantly during the NREM Stage 2 to Stage 3 transition, releasing norepinephrine throughout the central and peripheral nervous system as if genuine danger has been detected
• Autonomic storm: the norepinephrine discharge activates the sympathetic nervous system before full consciousness is achieved, producing tachycardia exceeding 120 bpm, rapid shallow breathing, sweating, chest pressure, and trembling while NREM arousal is still completing
• Amplification feedback loop: upon full awakening with no visible threat present, the brain interprets severe cardiovascular symptoms as evidence of cardiac arrest or suffocation; the resulting fear generates additional catecholamine release that sustains and amplifies the original locus coeruleus trigger through a bidirectional panic-physiology feedback mechanism

Carbon Dioxide Hypersensitivity and the False Suffocation Alarm

The false suffocation alarm theory (Klein, 1993) proposes that individuals with panic disorder have a hypersensitive brainstem CO2 detector that misinterprets normal NREM-related carbon dioxide fluctuations as imminent suffocation, triggering a full panic activation without any actual respiratory compromise.

How CO2 hypersensitivity generates nocturnal panic attacks:

• Normal NREM CO2 dynamics: respiratory rate and metabolic activity decrease during NREM sleep, causing blood CO2 to rise slightly; healthy brainstem CO2 receptors tolerate this shift without triggering arousal
• Hypersensitive suffocation monitor: panic disorder is associated with a lower CO2 threshold for activating the brainstem emergency arousal system; normal NREM-related CO2 elevation exceeds this lowered threshold and fires the suffocation alarm without physiological justification
• False alarm cascade: the brainstem activates the emergency arousal and autonomic activation sequence as if asphyxia is imminent; the individual wakes gasping, hyperventilating, with overwhelming fear of dying despite normal blood oxygen saturation levels
• OSA amplification: individuals with comorbid obstructive sleep apnea experience genuine nocturnal CO2 elevation and hypoxic episodes that reliably activate the hypersensitive CO2 alarm, creating clinical overlap requiring polysomnographic differentiation

Interoceptive Conditioning and Anxiety Sensitivity

Interoceptive conditioning sustains nocturnal panic attacks by training the amygdala to generate conditioned fear responses to normal NREM physiological changes that healthy individuals experience as neutral.

How interoceptive conditioning perpetuates nighttime panic attacks:

• Initial fear memory formation: the first nocturnal panic attack encodes a powerful associative fear memory linking tachycardia, dyspnea, and chest pressure with extreme danger, creating a template the amygdala activates upon detecting similar sensations
• Conditioned NREM hypervigilance: the amygdala monitors interoceptive signals during NREM sleep; subsequent normal cardiac and respiratory fluctuations at the NREM Stage 2 to Stage 3 transition reactivate the conditioned fear response before the individual reaches full consciousness
• Anxiety sensitivity amplification: individuals high in anxiety sensitivity (the trait of interpreting physiological sensations as harmful) demonstrate hyperactivated interoceptive monitoring during sleep; research confirms anxiety sensitivity directly predicts nocturnal panic occurrence and attack severity in panic disorder populations

Risk Factors Associated with Nocturnal Panic Attacks

Multiple clinical conditions elevate nocturnal panic attack probability through distinct neurobiological pathways that compound the locus coeruleus dysregulation driving primary panic disorder.

Risk factors with the strongest documented associations to nighttime panic attacks:

• Panic disorder (PD): the primary diagnostic association; over 50% of panic disorder patients report nocturnal attacks; primary nocturnal, daytime, and mixed presentation subtypes demonstrate clinically distinct severity profiles and treatment response characteristics
• PTSD: elevated nocturnal locus coeruleus norepinephrine output in PTSD fails to show the normal nighttime decline, maintaining persistent sympathetic hyperactivation that primes spontaneous nocturnal panic independent of dreaming; nocturnal MHPG (norepinephrine metabolite) levels in combat PTSD correlate directly with reduced total sleep time
• Generalized anxiety disorder (GAD): chronic cognitive hyperarousal and elevated baseline sympathetic tone reduce the threshold for NREM-stage locus coeruleus spontaneous activation
• Obstructive sleep apnea (OSA): repeated nocturnal CO2 elevation and hypoxic episodes directly activate the false suffocation alarm system; OSA must be excluded by polysomnography before nocturnal panic disorder is confirmed
• Major depressive disorder (MDD): 17 of 20 nocturnal panic patients (85%) in one polysomnographic study had comorbid depression, reflecting the bidirectional pathway between NREM sleep disruption and monoaminergic system depletion
• Hypoglycemia: nocturnal blood glucose drops trigger adrenal epinephrine release that produces autonomic activation mimicking panic and can precipitate genuine attacks in metabolically susceptible individuals
• Alcohol and benzodiazepine withdrawal: GABA-A receptor downregulation during cessation produces nocturnal noradrenergic hyperreactivity that generates panic-like arousal events at NREM transitions

Individuals managing co-occurring anxiety and substance use conditions should be specifically assessed for nocturnal panic attacks at dual diagnosis intake, as these conditions share neurobiological substrates that reinforce each other.

How Long Do Nocturnal Panic Attacks Last?

The acute phase of a nocturnal panic attack peaks within 5 to 10 minutes and resolves within 20 to 30 minutes, but residual arousal, hypervigilance, and fear of returning to sleep extend the full episode experience to 1 to 3 hours or through the remainder of the night.

1- Acute Onset Phase (Minutes 0 to 5)

The acute onset phase of a nocturnal panic attack delivers peak sympathetic activation while the individual is still completing the NREM-to-wakefulness transition.

Acute onset clinical features:

• Sympathetic activation precedes full wakefulness: tachycardia, gasping, sweating, and chest pressure begin while NREM arousal is still completing, producing the terrifying experience of waking already at peak distress with no apparent cause
• Heart rate reaches 120 to 160 bpm within the first 2 to 3 minutes; the sensation of imminent cardiac arrest or suffocation is most intense during this first window before cognitive reorientation establishes environmental safety
• Complete wakefulness is achieved rapidly: the individual becomes fully conscious with intact environmental awareness, distinguishing the experience from sleep terrors in which partial arousal produces confusion and inability to communicate

2- Peak and Plateau Phase (Minutes 5 to 20)

During the peak and plateau phase, full physical symptom intensity is maintained while cognitive catastrophizing amplifies the autonomic activation through a self-sustaining feedback loop.

Peak phase clinical features:

• Full physical symptom profile: trembling, nausea, derealization, depersonalization, numbness or tingling in extremities, and hot or cold flashes sustain alongside tachycardia and dyspnea throughout this window
• Catastrophic cognition drives secondary activation: fear of dying, fear of cardiac arrest, and the urge to call emergency services are most intense during minutes 5 to 20, catastrophic cognitive appraisal releases additional catecholamines that sustain sympathetic tone beyond the original locus coeruleus trigger
• Emergency department utilization peaks during this phase: individuals unable to distinguish nocturnal panic cardiovascular symptoms from myocardial infarction call emergency services, producing repeated ED visits and extensive cardiac workups before panic disorder is identified

3- Recovery and Aftermath Phase (Minutes 20 to Hours)

Physical symptoms begin resolving after 20 to 30 minutes, but residual arousal and hypervigilance generate a prolonged aftermath that drives the behavioral changes most damaging to long-term sleep health.

Recovery phase features:

• Physiological normalization: heart rate and respiratory rate return toward baseline within 20 to 30 minutes; sweating, trembling, and chest tightness gradually resolve as norepinephrine and epinephrine clear from systemic circulation
• Residual hypervigilance extends beyond physical resolution: fear of a second attack sustains sympathetic tone above sleep-onset threshold for 1 to 3 hours; most individuals cannot return to sleep and remain awake until cortisol and catecholamine levels normalize or morning arrives
• Sleep avoidance behavior development: after repeated attacks, individuals delay bedtime, sleep with lights on, vacate the bedroom, or require another person present; these conditioned safety behaviors create amygdala-mediated arousal in the sleep environment that perpetuates insomnia independently of panic disorder

Nocturnal Panic Attacks During Pregnancy

Pregnancy modifies several neurobiological systems involved in nocturnal panic generation, elevating risk and requiring treatment modifications specific to gestation.

Pregnancy-specific considerations for nighttime panic attacks:

• Progesterone sensitizes brainstem CO2 receptors: elevated progesterone during pregnancy increases respiratory center sensitivity to CO2, raising the probability that normal NREM-related CO2 fluctuations will exceed the false suffocation alarm threshold in individuals predisposed to panic
• Late-pregnancy sleep architecture changes compound risk: physical discomfort, urinary frequency, and fetal movement increase NREM Stage 1 time and reduce slow-wave sleep depth, lowering the arousal threshold and increasing NREM transition frequency
• Treatment hierarchy: CBT-based interventions are first-line treatment during pregnancy; benzodiazepines and specific SSRIs require careful risk-benefit evaluation with obstetric psychiatry before initiation

Symptoms and Impacts of Nocturnal Panic Attacks

Nocturnal panic attacks produce symptoms across physiological, psychological, and autonomic domains, and their cumulative impact on sleep architecture, mental health, and functional capacity substantially exceeds the distress of the acute episodes themselves.

Common Nocturnal Panic Attack Symptoms

Nocturnal panic attacks produce these symptoms consistently across DSM-5 diagnostic criteria, polysomnographic research, and clinical case series.

Common symptoms appearing during the acute phase:

• Tachycardia and palpitations: heart pounding, racing, or skipping is the first sensation experienced upon awakening; the absence of physical exertion preceding the tachycardia is the primary clinical differentiator from cardiac events and distinguishes panic from exercise-induced arrhythmia
• Dyspnea and chest tightness: shortness of breath and chest pain arrive simultaneously with tachycardia and are the primary drivers of emergency department visits; locus coeruleus-mediated sympathetic activation produces these symptoms through catecholamine-driven cardiovascular effects, not structural cardiac pathology
• Diaphoresis and trembling: profuse sweating and uncontrollable shaking driven by elevated circulating norepinephrine and epinephrine from the sympathetic nervous system; trembling persists into the recovery phase as catecholamines clear from systemic circulation
• Choking and smothering sensations: consistent with CO2 hypersensitivity activating the false suffocation alarm; the sensation of inability to obtain sufficient air despite normal blood oxygen saturation is characteristic and differentiates CO2-driven panic from true respiratory pathology
• Derealization and depersonalization: the abrupt NREM-to-wakefulness transition under extreme autonomic activation produces dissociative phenomenology; the amygdala generates threat responses faster than the prefrontal cortex can establish environmental safety, creating a brief window of unreality

Severe Presentations and When to Seek Emergency Care

Certain nocturnal awakening presentations require immediate medical evaluation to exclude cardiac, neurological, and metabolic emergencies before panic disorder is confirmed as the diagnosis.

Seek emergency medical care immediately if nocturnal awakening produces any of the following:

1. Chest pain radiating to the jaw, left arm, or back requires cardiac emergency evaluation to rule out myocardial infarction before panic disorder diagnosis can proceed
2. Loss of consciousness, even briefly may indicate cardiac arrhythmia or seizure, requiring urgent ECG and neurological evaluation
3. Sustained irregular heart rhythm distinct from simple tachycardia cardiac workup required before attributing to sympathetic nervous system activation from panic
4. Symptoms not resolving within 30 minutes atypical for panic disorder and warrants urgent clinical assessment
5. First nocturnal episode in anyone over 40 or with known cardiovascular risk factors cardiac etiology must be excluded before panic disorder diagnosis is accepted

Severe behavioral consequences of recurrent nocturnal panic attacks:

• Progressive insomnia from conditioned bedroom arousal: repeated nocturnal attacks destroy the psychological safety required for sleep onset; the amygdala encodes the bedroom as a danger context, and conditioned arousal perpetuates insomnia independently of panic disorder itself
• Agoraphobic avoidance of unfamiliar sleep environments: anticipatory anxiety about experiencing attacks in locations outside the individual’s controlled home generates avoidance of travel, overnight stays, and any sleep context where help is not immediately accessible
• Escalating emergency department utilization: the inability to distinguish nocturnal panic cardiovascular symptoms from cardiac events produces repeated ED visits, extensive cardiac and neurological workups, and months of misdiagnosis before panic disorder is correctly identified

Long-Term Impacts of Untreated Nocturnal Panic Attacks

Untreated nocturnal panic attacks produce progressive neurobiological consequences that amplify the underlying anxiety disorder and generate co-occurring conditions with independent clinical severity.

Long-term impacts documented across clinical and polysomnographic research:

• Chronic HPA axis dysregulation: repeated nocturnal cortisol surges from panic activation gradually blunt the cortisol awakening response, increase baseline physiological stress reactivity, and heighten anxiety sensitivity in ways that persist beyond the period of active panic disorder
• Comorbid depression development: the 85% depression co-occurrence rate in polysomnographic studies reflects the bidirectional pathway between nocturnal panic-driven sleep fragmentation and monoaminergic system depletion; chronic NREM disruption reduces serotonergic and dopaminergic recovery capacity, directly precipitating major depressive episodes
• Substance use as self-medication: alcohol and benzodiazepines temporarily suppress NREM locus coeruleus activation, providing short-term relief; negative reinforcement drives chronic self-medication, establishing substance dependence while simultaneously worsening sleep architecture and intensifying rebound nocturnal panic during withdrawal

Individuals experiencing co-occurring depression alongside nocturnal panic attacks require integrated treatment addressing both conditions concurrently; sequential single-disorder approaches fail to resolve the mutual-maintenance dynamic.

Treatment for Nocturnal Panic Attacks

Evidence-based anxiety treatment for nocturnal panic attacks targets locus coeruleus hyperreactivity, interoceptive conditioning, and conditioned sleep avoidance simultaneously, with CBT and SSRI pharmacotherapy providing the strongest long-term remission outcomes.

Cognitive Behavioral Therapy for Nocturnal Panic

CBT adapted specifically for nocturnal panic attacks is the gold-standard first-line treatment, directly reversing the interoceptive conditioning and catastrophic appraisal mechanisms that sustain the attack cycle.

CBT components most effective for nighttime panic attacks:

• Interoceptive exposure: graduated, systematic exposure to panic-associated physiological sensations (elevated heart rate, breathlessness, dizziness) reduces amygdala conditioned fear responses to these sensations, lowering the probability that normal NREM cardiac and respiratory fluctuations trigger full panic activation
• Cognitive restructuring: identifying and correcting catastrophic appraisals of nocturnal sensations disrupts the secondary catecholamine-release loop that sustains peak-phase intensity; reframing tachycardia as sympathetic nervous system overreaction rather than cardiac emergency reduces fear-driven amplification
• CBT for insomnia (CBT-I) integration: sleep restriction, stimulus control, and sleep hygiene components address amygdala-mediated conditioned arousal in the bedroom, rebuilding the psychological sleep safety that nocturnal panic destroys
• Sleep avoidance reversal: graduated reintroduction of normal sleep behaviors eliminates agoraphobic safety behaviors (lights-on sleeping, requiring company, bedroom avoidance) that perpetuate both panic disorder and chronic insomnia

Evidence-based cognitive behavioral therapy for panic disorder produces durable long-term remission by reversing interoceptive conditioning, achieving outcomes that pharmacological treatment alone cannot sustain after discontinuation.

Pharmacological Treatment

Pharmacological treatment reduces locus coeruleus hyperreactivity and supports the acute phase of treatment while CBT skills are being consolidated through practice.

First-line pharmacological options for nocturnal panic disorder:

• SSRIs and SNRIs: paroxetine, sertraline, escitalopram, and venlafaxine reduce locus coeruleus reactivity and sensitize 5-HT1A receptors that modulate the noradrenergic stress response; full therapeutic effect requires 4 to 8 weeks at therapeutic dosage; SSRIs are preferred when comorbid depression or GAD is present
• Tricyclic antidepressants (TCAs): imipramine and clomipramine demonstrate robust efficacy for panic disorder; their sedating properties provide additional benefit for the insomnia component of nocturnal panic presentations when SSRIs and SNRIs are not tolerated
• Benzodiazepines as short-term adjunct only: clonazepam and alprazolam reduce acute panic attack frequency but are not first-line for long-term treatment due to dependence risk, rebound anxiety upon discontinuation, and paradoxical sleep architecture worsening with chronic use that increases nocturnal arousal propensity
• Sleep augmentation: short-term hypnotic adjuncts evaluated individually when insomnia severity significantly impairs function; eszopiclone combined with SSRIs has demonstrated clinical potential specifically for nocturnal panic presentations

Addressing Underlying Conditions

Treating conditions that amplify nocturnal panic attack frequency is essential for achieving stable remission rather than partial, unstable symptom reduction.

Priority evaluations and treatment targets:

• Obstructive sleep apnea: polysomnography with full respiratory monitoring differentiates OSA-driven nocturnal arousals from primary panic disorder; CPAP treatment eliminates genuine CO2 fluctuations that activate the hypersensitive suffocation alarm in a significant subset of patients
• PTSD: prolonged exposure, EMDR, and CPT address the elevated nocturnal locus coeruleus norepinephrine output that sustains spontaneous nocturnal panic independently of panic disorder treatment; panic-focused CBT alone produces incomplete and unstable remission when active PTSD is untreated
• Hypoglycemia: nocturnal glucose monitoring and dietary modifications eliminate adrenal epinephrine-driven nocturnal arousal that mimics and precipitates panic in metabolically susceptible individuals
• Alcohol and benzodiazepine cessation: withdrawal-phase GABA-A rebound dramatically worsens nocturnal panic; tapering must be gradual and medically supervised to prevent precipitating a panic cascade during the noradrenergic hyperreactivity of cessation

Individuals who have used substances to self-manage nocturnal panic should receive a comprehensive evaluation for substance use patterns to determine whether integrated addiction treatment is required alongside anxiety disorder care.

Treatment at Olympic Behavioral Health

Olympic Behavioral Health provides evidence-based PHP, IOP, and dual diagnosis treatment for panic disorder, PTSD, and co-occurring mental health conditions in Lantana, Florida, with individualized CBT, EMDR, neurofeedback, and psychiatric evaluation integrated across all program levels.

Partial Hospitalization Program (PHP)

Olympic Behavioral Health’s PHP delivers 6 hours of structured daily clinical programming on weekdays and 3 hours on weekends, Monday through Sunday, providing intensive support for individuals whose nocturnal panic attacks have produced significant sleep disruption, occupational impairment, or progressive agoraphobia that outpaces standard outpatient care.

PHP components applicable to nocturnal panic disorder:

• CBT groups: structured CBT groups address catastrophic appraisals, safety behaviors, and bedroom avoidance patterns; psychoeducation on NREM sleep mechanisms, CO2 hypersensitivity, and the false suffocation alarm normalizes the neurobiology and removes the catastrophic misinterpretation that amplifies attack severity and duration
• DBT skills training: dialectical behavior therapy provides distress tolerance techniques that interrupt the catecholamine-releasing cognitive amplification loop during acute nocturnal panic, reducing peak-phase duration and intensity
• Individual therapy: weekly 50-minute sessions with a licensed primary therapist deliver personalized interoceptive exposure planning, CBT-I behavioral interventions, and trauma processing when PTSD underlies the nocturnal panic presentation

Intensive Outpatient Program (IOP)

Olympic Behavioral Health’s IOP delivers 9 clinical hours per week across three evening sessions, providing evidence-based nocturnal panic disorder treatment for individuals managing the condition alongside work, family, or school commitments.

IOP components supporting nocturnal panic recovery:

• EMDR and rapid trauma resolution: EMDR addresses traumatic memory networks sustaining elevated nocturnal locus coeruleus norepinephrine output, directly reducing both PTSD-driven nightmares and nocturnal panic attacks in individuals whose presentations are trauma-rooted
• Neurofeedback therapy: neurofeedback addresses cortical hyperarousal and autonomic dysregulation underlying panic disorder and the sleep architecture disruption documented by polysomnography in nocturnal panic patients
• Psychoeducation groups: evidence-based education on panic disorder neurobiology, CO2 hypersensitivity, interoceptive conditioning, and NREM sleep mechanisms empowers patients to reframe attacks and reduce the catastrophic misinterpretation that sustains attack severity

Individuals ready to begin treatment can explore substance abuse and mental health treatment programs at Olympic Behavioral Health. Same-day clinical assessment is available.

Dual Diagnosis Psychiatric Evaluation

Olympic Behavioral Health’s board-certified psychiatrist Dr. Nvari and psychiatric ARNP Sabina conduct DSM-5 dual diagnosis evaluations for individuals presenting with panic disorder, PTSD, major depressive disorder, and co-occurring substance use disorders.

Dual diagnosis services directly applicable to nocturnal panic presentations:

• Panic Disorder Severity Scale (PDSS) assessment: standardized measurement of attack frequency, anticipatory anxiety, avoidance severity, and functional impairment at intake and throughout treatment provides objective monitoring of treatment response and informs medication adjustment decisions
• Integrated pharmacological and behavioral management: SSRI initiation alongside CBT maximizes combined efficacy; Olympic Behavioral Health’s psychiatry team evaluates medication appropriateness, monitors for adverse effects, and coordinates with behavioral therapy staff to optimize the dual-approach outcome
• DSM-5 differential evaluation: distinguishing panic disorder with nocturnal specifier from PTSD-driven nocturnal arousal, OSA, hypoglycemia, and nocturnal seizure requires systematic clinical assessment; Olympic Behavioral Health applies this diagnostic rigor at intake to ensure treatment is matched to the actual neurobiological driver

Same-day clinical assessment and admission is available for individuals ready to address nocturnal panic attacks.